LINC01607

Across TCGA pan-cancer cohorts, LINC01607 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC01607’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01607 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01607 is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, THCA, and LUAD are the cancer types where LINC01607 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01607 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−0.803	<.001	10	view →
THCA	Male	III,IV	−1.372	<.001	9	view →
LUAD	Female	III,IV	+1.387	<.001	8	view →
LIHC	Male	All	+0.656	<.001	8	view →
HNSC	Male	IV	+0.774	.005	7	view →
LUSC	Female	All	+1.411	<.001	6	view →
UCEC	All	All	+1.068	<.001	6	view →
KICH	All	II,III,IV	+0.835	.016	3	view →
STAD	All	All	+0.270	.004	3	view →
COAD	All	All	+0.249	.004	3	view →
CHOL	All	All	+1.191	.009	2	view →
PRAD	All	All	+0.437	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC01607–KIRC

Open the KIRC breakdown →